5 recruiting, 2 completed, 1 active not recruiting, 1 not yet recruiting. 10 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Recruiting 5, Completed 2, Active not recruiting 1, Not yet recruiting 1, Terminated 1 |
Follow Breast Cancer Invasive: new trials by email Literature Review of Breast Cancer Invasive trials Research Report on Breast Cancer Invasive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant, SBRT With Intratumoural Pembrolizumab Followed by Neoadjuvant Chemotherapy in Breast Cancer Radiation, Pembrolizumab (KEYTRUDA®) - Breast Cancer, Breast Cancer Stage II | Phase 2 | Recruiting | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 40 | 2026-01-19 | 2026-02-11 |
| Neoadjuvant Treatment of Triple-Negative Breast Cancer with Stereotactic Radiotherapy, PD-1 Monoclonal Antibody, and Chemotherapy neoadjuvant SBRT combined with PD-1 monoclonal antibody and chemotherapy - Breast Cancer Invasive | Phase 2 | Not yet recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 20 | 2025-02-01 | 2025-02-20 |
| Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in ER-positive Breast Cancer Fluoroestradiol (18F) - Breast Cancer Invasive | Phase 2 | Completed | Asan Medical Center | 71 | 2024-11-18 | 2025-12-02 |
| Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy Tart Cherry Juice - Breast Cancer, Breast Cancer Stage I | Phase 2 | Recruiting | University of California, Davis | 86 | 2024-08-15 | 2026-03-04 |
| Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer Paclitaxel, Carboplatin, Trastuzumab - Breast Cancer, Breast Neoplasm | Phase 2 | Recruiting | Baylor Breast Care Center | 185 | 2023-04-18 | 2025-02-27 |
| COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study Surgery, Radiotherapy, Radiofrequent ablation - Breast Cancer Invasive, Metastatic Cancer | Phase 2 | Recruiting | The Netherlands Cancer Institute | 56 | 2023-04-17 | 2026-09-11 |
| BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer Azacitidine - Breast Cancer Invasive, Early-stage Breast Cancer | Phase 2 | Recruiting | University of Illinois Chicago | 50 | 2022-01-10 | 2026-11-06 |
| Milademetan in Advanced/Metastatic Solid Tumors RAIN-32 - Solid Tumors, Head and Neck Carcinoma | Phase 2 | Terminated | Rain Oncology Inc | 40 | 2021-11-01 | 2024-10-17 |
| Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Pyrotinib, Trastuzumab, Pertuzumab - Breast Cancer Invasive | Phase 2 | Active not recruiting | Shanghai Jiao Tong University School of Medicine | 216 | 2020-05-30 | 2022-03-31 |
| Prospective, Multicentric Study Evaluating the Surgical Treatment by Mastectomy With Immediate Prosthetic Breast Reconstruction in Patients With Breast Cancer and Receiving Adjuvant Therapy by TomoTherapy +/-Chemotherapy. Mastectomy with Immediate prosthetic breast reconstruction and adjuvant tomotherapy - Breast Cancer Invasive | Phase 2 | Completed | Institut Claudius Regaud | 66 | 2019-06-07 | 2026-05-22 |
Breast Neoplasms (4) · Triple Negative Breast Neoplasms (3) · Ovarian Neoplasms (2) · Adenocarcinoma of Lung (1) · Adrenocortical Carcinoma (1) · Biliary Tract Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Cholangiocarcinoma (1) · Melanoma (1) · Neoplasm Metastasis (1) · Pancreatic Neoplasms (1) · Sarcoma (1) · Stomach Neoplasms (1) · Testicular Germ Cell Tumor (1) · Uterine Cervical Neoplasms (1)
Neoplasms (7) · Neoplasms by Site (6) · Skin Diseases (6) · Skin and Connective Tissue Diseases (6) · Breast Diseases (5) · Adnexal Diseases (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Genital Neoplasms, Female (2) · Gonadal Disorders (2) · Ovarian Diseases (2)
Surgical Procedures, Operative (2) · Trastuzumab (2) · pembrolizumab (2) · pertuzumab (2) · 130-nm albumin-bound paclitaxel (1) · Azacitidine (1) · Carboplatin (1) · Cyclophosphamide (1) · Doxorubicin (1) · Drug Therapy (1) · Immunotherapy (1) · Mastectomy (1) · Paclitaxel (1) · Radiation (1) · Radiotherapy (1)
Asan Medical Center (1) · Baylor Breast Care Center (1) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1) · Institut Claudius Regaud (1) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1) · Rain Oncology Inc (1) · Shanghai Jiao Tong University School of Medicine (1) · The Netherlands Cancer Institute (1) · University of California, Davis (1) · University of Illinois Chicago (1)
United States (4) · Canada (1) · China (1) · France (1) · Netherlands (1) · South Korea (1)
Eve Rodler, MD (1) · G Sonke (1) · Kunwei Shen, MD,PhD (1) · Mothaffar Rimawi, MD (1) · Sangwon Han, Clinical assistant professor (1) · Vijayakrishna Krishnamurthy Gadi, MD, PhD (1)